| Ytd | 20.76% | |
| 1y | 30.62% |
| Open | 116.51 | Prev Close | 117.50 | Low | 116.22 | High | 117.78 | Mkt Cap | 13.03B |
| Vol | 588.99K | Avg Vol | 1.50M | EPS | 5.35 | P/E | 21.84 | Forward P/E | 19.82 |
| Beta | 1.07 | Short Ratio | 5.11 | Inst. Own | 107.03% | Dividend | 0.28 | Div Yield | 0.24 |
| Ex Div Date | 10-23 | Earning | 08-04 | 50-d Avg | 109.03 | 200-d Avg | 99.83 | 1yr Est | 121.07 |
Assenagon Asset Management S.A. lessened its stake in Revvity Inc. (NYSE: RVTY) by 35.5% in the unde
RVTY launches SuperFlex, a compact automated prenatal screening system aimed at expanding rapid in-h
Cetera Investment Advisers raised its position in Revvity Inc. (NYSE: RVTY) by 59.8% during the firs
[url="]Revvity, Inc.[/url] (NYSE: RVTY), today announced it will present at the following investor c
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced it will present at the
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. today announced the launch of the SuperFlex™ prenatal
Revvity NYSE: RVTY reported second-quarter results above its expectations and raised its full-year o
Revvity beats Q2 earnings and sales estimates as Diagnostics growth, wider margins and strong cash f
Revvity, Inc. (RVTY) Q2 2026 Earnings Call Transcript
Medical equipment maker Revvity raised its annual profit and revenue forecasts on Tuesday, after t
Revvity (RVTY) came out with quarterly earnings of $1.41 per share, beating the Zacks Consensus Esti
Revvity Inc (RVTY) released its 8-K filing detailing its earnings for the second quarter of 2026 on
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for th
WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declare
Revvity, Inc. RVTY is slated to report second-quarter 2026 results on Aug. 4, before market open.
Revvity (RVTY) doesn't possess the right combination of the two key ingredients for a likely earning
Bank of Nova Scotia lifted its position in shares of Revvity Inc. (NYSE: RVTY) by 436.4% in the unde
RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater l
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. today announced the development of the T-SPOT™ A201,
RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to st
Companies Reporting Before The Bell • Keurig Dr Pepper (NASDAQ:KDP) is projected to report quarterl
Friday's session saw 225 companies set new 52-week lows.
On Wednesday, 179 companies reached new 52-week lows.
Assad-era officer convicted in Austria returns to Syria a free man, sources say A former Syrian secu
German companies cut US investment to three-year low, data show German companies slashed investments
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver
Thermo Fisher rated Buy: accelerating organic growth, margin gains, and acquisitions boosting Pharma